Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

Well then that means our market is too small. If the news was good enough, new investors would overpower any manipulation.

Admittedly, at this price on this exchange, our pool of investors is fairly small. We expanded that pool back on the first COVID run but used up the momentum by raising the $6M we needed to survive.

Back when the preclinical news was fresh and exciting, even expanding the share count by over 50 million could only hold us to 4x gains over a few days. Manipulation is no match for actual enthusiasm.

Now, as I have been saying, we need something meatier than pre-clinical data to entice new investors to buy in. Hopefully we get it soon.

Go IPIX!